Ovarian cancer future or investigational therapies: Difference between revisions
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
[[Epithelial ovarian cancer]] patients can have better [[prognosis]] and outcome with some under trial [[Medications]] that believed to be promising in the future. Examples of the [[mechanism of action]] of these promising [[drugs]] are, targeting the [[angiogenesis]], targeting (inhibit) [[DNA]] | [[Epithelial ovarian cancer]] patients can have better [[prognosis]] and outcome with some under trial [[Medications]] that believed to be promising in the future. Examples of the [[mechanism of action]] of these promising [[drugs]] are, targeting the [[angiogenesis]], targeting (inhibit) [[DNA|DNA repair]], targeting [[cell cycle]], targeting signaling [[pathways]], immunotherapeutic [[medications]]. | ||
==Investigational therapies== | ==Investigational therapies== | ||
*Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future | *[[Epithelial ovarian cancer]] patients can have better [[prognosis]] and outcome with some under trial [[Medications]] that believed to be promising in the future | ||
*Examples of the mechanism of action of these promising drugs are: | *Examples of the [[mechanism of action]] of these promising [[drugs]] are: | ||
**Targeting the angiogenesis | **Targeting the [[angiogenesis]] | ||
**Targeting (inhibit) DNA repair | **Targeting (inhibit) [[DNA repair]] | ||
**Targeting cell cycle | **Targeting [[cell cycle]] | ||
**Targeting signaling pathways | **Targeting signaling pathways | ||
**Immunotherapeutic medications | **Immunotherapeutic [[medications]] | ||
== References == | == References == | ||
Latest revision as of 20:06, 24 July 2019
|
Ovarian cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian cancer future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Ovarian cancer future or investigational therapies |
|
Ovarian cancer future or investigational therapies in the news |
|
Risk calculators and risk factors for Ovarian cancer future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Huda A. Karman, M.D.
Overview
Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future. Examples of the mechanism of action of these promising drugs are, targeting the angiogenesis, targeting (inhibit) DNA repair, targeting cell cycle, targeting signaling pathways, immunotherapeutic medications.
Investigational therapies
- Epithelial ovarian cancer patients can have better prognosis and outcome with some under trial Medications that believed to be promising in the future
- Examples of the mechanism of action of these promising drugs are:
- Targeting the angiogenesis
- Targeting (inhibit) DNA repair
- Targeting cell cycle
- Targeting signaling pathways
- Immunotherapeutic medications